News - Qnexa

Filter

Current filters:

Qnexa

Popular Filters

US FDA approves second diet pill, Vivus' Qsymia

18-07-2012

In a much anticipated but largely expected decision, the US Food and Drug Administration yesterday approved…

MetabolicsNorth AmericaPharmaceuticalQnexaQsymiaRegulationVivus

EMA agrees more time for Vivus to prepare for Qnexa oral hearings

05-06-2012

US drug developer Vivus (Nasdaq: VVUS) says that the European Medicines Agency's Committee for Medicinal…

EuropeMetabolicsPharmaceuticalQnexaRegulationVivus

Vivus says FDA has delayed Qnexa PDUFA date

10-04-2012

The US Food and Drug Administration has advised informed USA-based rug developer Vivus (Nasdaq: VVUS)…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

FDA advisory panel backs approval of Qnexa

23-02-2012

At last there was finally some good news for drug developer Vivus (Nasdaq: VVUS) - and Americans with…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

FDA updates on obesity drug candidates

11-01-2012

There have been two pieces of positive news coming out of the US Food and Drug Administration this week…

Arena PharmaceuticalsEisailorcaserinLorquessMetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Vivus findings show greater risk of birth defects with Qnexa ingredient

23-12-2011

USA-based drug developer Vivus (Nasdaq: VVUS) has released top-line preliminary results from its retrospective…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationResearchtopiramateVivus

FDA accepts VIVUS NDA filing for Qnexa with PDUFA set for April 2012

08-11-2011

There was good news for US drugmaker VIVUS (Nasdaq: VVUS) in its long-running battle to get its weight-loss…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Another stab at obesity drug approval, as VIVUS resubmits Qnexa to the FDA

17-10-2011

In the long-running battle to gets its obesity drug cleared for marketing, VIVUS (Nasdaq: VVUS) said…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Vivus agrees pathway with US FDA for re-submission of Qnexa NDA

16-09-2011

There was a shot in the arm for US drug developer Vivus (Nasdaq: VVUS) yesterday, when the company said…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

ADA meeting hears news of XOMA’s new classes of insulin receptor-regulating Ab and Vivus’ Qnexa

27-06-2011

US therapeutic antibody discovery firm XOMA (Nasdaq: XOMA) presented results from its discovery of two…

PharmaceuticalQnexaVivusXOMA Corp

Back to top